Adjuvant Systemic Chemotherapy With or Without HAI-FUDR in Patients With Resected CRLM (NCT03500874) | Clinical Trial Compass
TerminatedPhase 3
Adjuvant Systemic Chemotherapy With or Without HAI-FUDR in Patients With Resected CRLM
Stopped: The study was terminated prematurely due to FUDR production halt in China
China92 participantsStarted 2018-05-28
Plain-language summary
HARVEST is an investigator-initiated prospective randomized controlled study comparing adjuvant intravenous systemic chemotherapy with or without HAI- floxuridine (FUDR) in CRC patients post-liver metastasectomy.
Who can participate
Age range18 Years – 75 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. The primary lesion has undergone or is capable of radical resection, and liver metastases can undergo R0/R1 resection (including intraoperative interventional ablation therapy), and postoperative achievement of no evidence of disease (NED).